PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 29 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $7,434,000 | -12.5% | 13,275,000 | 0.0% | 0.33% | -20.4% |
| Q2 2016 | $8,496,000 | -23.9% | 13,275,000 | 0.0% | 0.41% | -37.1% |
| Q1 2016 | $11,158,000 | -17.6% | 13,275,000 | 0.0% | 0.65% | -25.4% |
| Q4 2015 | $13,541,000 | +57.7% | 13,275,000 | +82.5% | 0.88% | +19.0% |
| Q3 2015 | $8,584,000 | -39.5% | 7,274,577 | 0.0% | 0.74% | -23.9% |
| Q2 2015 | $14,185,000 | +105.5% | 7,274,577 | -19.2% | 0.97% | +95.9% |
| Q1 2015 | $6,904,000 | +87.6% | 9,000,000 | +350.0% | 0.49% | +101.2% |
| Q4 2014 | $3,680,000 | -24.0% | 2,000,000 | 0.0% | 0.24% | -46.2% |
| Q3 2014 | $4,840,000 | -33.7% | 2,000,000 | 0.0% | 0.46% | -4.8% |
| Q2 2014 | $7,300,000 | -20.3% | 2,000,000 | 0.0% | 0.48% | -33.4% |
| Q1 2014 | $9,160,000 | +17.7% | 2,000,000 | 0.0% | 0.72% | +4.7% |
| Q4 2013 | $7,780,000 | -4.1% | 2,000,000 | +11.7% | 0.69% | -19.3% |
| Q3 2013 | $8,109,000 | +10.1% | 1,790,000 | +19.3% | 0.85% | +12.1% |
| Q2 2013 | $7,365,000 | – | 1,500,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,825,000 | $1,206,000 | 0.39% |
| Zhang Financial LLC | 45,000 | $33,000 | 0.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 472,553 | $313,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 127,062 | $85,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $215,000,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $200,000 | 0.00% |
| Renaissance Technologies | 1,993,500 | $1,318,000 | 0.00% |
| WEDBUSH SECURITIES INC | 15,000 | $10,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 57,127 | $38,000 | 0.00% |
| Psagot Value Holdings Ltd. | 29,193 | $20,000 | 0.00% |